NewAmsterdam Pharma N.V. - Wutah bathi EPS kuartalan NAMS

NewAmsterdam Pharma Corp - logo grafis emiten NAMS

NewAmsterdam Pharma (NAMS) is fighting for the cardiometabolic market amid intense pressure from low-cost generics. Quarterly earnings per share growth reflects the depth of the revenue decline, while the 76.10 metric serves as the target level. The development of a breakthrough CETP inhibitor provides a technological leap, and successful clinical trials strengthen the medical community's confidence in this young biopharmaceutical brand.

NewAmsterdam Pharma Company N.V. (NAMS) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan saka 21.06.2023 nganti 17.11.2026

Rincian metrik keuangan lan pasar NewAmsterdam Pharma (NAMS)

Analisis kabeh metrik perusahaan:NewAmsterdam Pharma
Produk asil prodhuksi NewAmsterdam Pharma Corp

Quarterly EPS growth measures the rate of change in net income per share, reflecting the actual acceleration of the business. Investors utilize this calculation to identify consolidation phases or momentum-driven capitalization growth. When analyzing the quarterly EPS chart, level breakouts should be confirmed by trading volumes. The stability of the biopharmaceutical sector minimizes geopolitical risks for NewAmsterdam Pharma (NAMS). This ensures the predictability of fundamental metrics during the development of global drugs.

Pesaing NewAmsterdam Pharma (NAMS)

ASND (Ascendis Pharma) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|MDGL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CORT (Corcept Therapeutics Corp) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan Rhythm Pharmaceuticals|Wutah bathi EPS kuartalan AKRO|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MTSR (Metsera, Inc.)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan moonlaketx.com MLTX|Crinetics Corp (CRNX) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|SLNO - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|FOLD: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|ETNB: Wutah bathi EPS kuartalan|AGIO - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Structure Corp|MiMedx Corp (MDXG) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan rezolutebio.com (RZLT)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan lexpharma.com LXRX|Wutah bathi EPS kuartalan MBX (MBX Biosciences)|Altimmune Corp - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Aardvark Therapeutics Inc. - Wutah bathi EPS kuartalan|SGMT - Wutah bathi EPS kuartalan|BioAge Labs (BIOA) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan biomeafusion.com (BMEA)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Quince Therapeutics, Inc.|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Fractyl (GUTS)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan VTVT (vTv Therapeutics Inc.)|ATPC - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Pluri Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham sajroning taun lumaku Synlogic Corp|LPCN - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Matinas BioPharma Holdings, Inc. MTNB|SPRB: Wutah bathi EPS kuartalan|Galecto Corp - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|CTCX (carmellrx.com) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan lumos-pharma.com|Wutah bathi EPS kuartalan ONVO|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Radius Health RDUS